122310 — Genoray Co Income Statement

0.000.00%

Last trade - 00:00

HealthcareConservativeMicro CapSuper Stock

Annual income statement for Genoray Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	61,688	74,290	82,604	97,897	106,982
Cost of Revenue
Gross Profit	25,977	30,992	35,261	37,544	39,536
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses	50,569	59,323	67,686	85,140	114,491
Operating Profit	11,119	14,968	14,918	12,757	-7,510
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	10,700	15,787	15,704	12,961	-5,988
Provision for Income Taxes
Net Income After Taxes	10,172	14,323	13,900	12,356	-2,537
Minority Interest
Net Income Before Extraordinary Items
Net Income	10,172	14,323	13,900	12,486	-1,797
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	10,172	14,323	13,900	12,486	-1,797
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	709	999	987	911	525
Dividends per Share